Is Ibuprofen or Aleve Better for Inflammation?

Compare Ibuprofen and Naproxen safety, speed, and duration to select the optimal NSAID for fast or sustained inflammation relief.

Neither ibuprofen nor naproxen (sold as Aleve) is universally better for inflammation. Both belong to the same drug class and block the same enzymes responsible for swelling and pain. The meaningful differences between them come down to how long each dose lasts, how they affect the stomach and heart over time, and how they interact with other medications you might already be taking. For most people, the choice depends less on raw anti-inflammatory power and more on the specific situation: what hurts, how long you need relief, and what other health concerns are in play.

The Biggest Practical Difference Is Duration

Ibuprofen has a short half-life of roughly two hours, which means it clears your system relatively fast. You typically need a dose every four to six hours to maintain its effect. Naproxen’s half-life is much longer, in the range of twelve to seventeen hours, so a single dose can cover you for up to twelve hours. That difference shapes everything: how often you reach for the bottle, how steady the drug level stays in your blood, and how consistently it suppresses inflammation throughout the day and night.

For a one-off headache or a mild tweak in your back, ibuprofen’s shorter action is not a disadvantage. You take a dose, the pain passes, and you stop. But for something that flares throughout the day, like arthritis or a recovering sprain, naproxen’s longer window means you can take it in the morning and at bedtime and stay reasonably covered. That twice-daily schedule also has a compliance advantage: research consistently shows that people stick to medication regimens better when they have to take fewer doses. A systematic review of compliance studies found that people following a four-times-daily schedule averaged roughly half the dose-taking compliance of those on a once- or twice-daily schedule.

Head-to-Head Efficacy in Acute Pain

In controlled trials, both ibuprofen and naproxen sodium outperform placebo by a wide margin for acute inflammatory pain. The interesting question is whether one pulls ahead of the other once the initial hours pass. In post-surgical dental pain, a common testing ground for analgesics, a randomized trial found that both drugs kicked in at about the same speed, with meaningful relief starting around thirty minutes after the dose. But naproxen held its advantage much longer. The greatest separation between the two drugs appeared between hours eight and fourteen, when naproxen was still working while ibuprofen’s effect had faded. In that trial, only about a third of naproxen patients needed rescue medication, compared with more than four in five ibuprofen patients.

An earlier dental surgery study showed a similar pattern: the median time before patients needed a backup painkiller was about six hours for ibuprofen and seven hours for naproxen, and naproxen was rated significantly better than ibuprofen at the eight- through twelve-hour marks. So ibuprofen is not weaker per dose in the first few hours. It just runs out sooner.

Chronic Joint Inflammation and Osteoarthritis

For ongoing conditions like knee osteoarthritis, both drugs reduce pain and stiffness from baseline. A trial of over four hundred patients found that naproxen sodium and ibuprofen each cut mean symptom scores by roughly a third to nearly half compared with about a quarter for placebo. Naproxen had a slight edge: it significantly improved all seven measured symptoms versus placebo, while ibuprofen improved five. Among patients aged sixty-five and older, the gap widened further. In that subgroup, naproxen remained significantly better than placebo across nearly all symptoms, whereas ibuprofen only significantly reduced daytime pain.

A crossover study in general practice patients with osteoarthritis told a similar story. Both drugs reduced stiffness, resting pain, movement pain, and night pain. But naproxen was rated superior for resting pain, movement pain, night pain, and interference with daily activities. When patients who started on ibuprofen switched to naproxen, they improved further. When patients who started on naproxen switched to ibuprofen, they did not. That asymmetry suggests naproxen’s longer duration of action translates into a real-world benefit for chronic pain, where inflammation does not pause between doses.

Not every study finds a dramatic difference, though. A more recent comparison in elderly patients with knee osteoarthritis found both drugs significantly reduced pain across all measures by one week, with naproxen and ibuprofen both described as effective and well-tolerated. If you are taking the right dose at the right intervals, ibuprofen can hold its own. The challenge is keeping that schedule up day after day.

Menstrual Cramps

Period pain is driven by prostaglandins, the same inflammatory molecules these drugs target, so both are effective. But a pooled analysis of five clinical trials found that naproxen provided significantly greater pain relief than ibuprofen at six hours after dosing. For menstrual cramps that persist through the day, naproxen’s longer coverage can mean fewer doses and more consistent relief. That said, ibuprofen’s faster clearance could be a plus if you only need a few hours of relief and prefer to minimize how long the drug stays in your system.

Cardiovascular Safety

This is where the conversation gets more serious, especially if you take anti-inflammatory drugs regularly. The PRECISION trial, the largest randomized safety study ever conducted for this class of drugs, followed over twenty-four thousand arthritis patients for an average of about three and a half years. Primary cardiovascular events occurred in about two and a half percent of naproxen patients and about two and seven-tenths percent of ibuprofen patients. The difference was small and not statistically significant, meaning neither drug emerged as clearly riskier for heart attacks or strokes in that population.

Naproxen has long carried a reputation as the “heart-friendliest” NSAID, partly because it inhibits platelet clumping for a longer stretch of each dosing interval. The PRECISION data did not dramatically undermine that idea, but it also did not confirm a large advantage. For most short-term users, the cardiovascular difference between the two drugs is probably negligible. For people taking either drug regularly over months, the conversation should happen with a doctor who knows their full cardiac risk profile.

Blood Pressure Effects

Separate from the heart-attack question, both drugs can raise blood pressure. A sub-study of the PRECISION trial that used twenty-four-hour ambulatory blood pressure monitoring found that ibuprofen raised systolic blood pressure by an average of about four points, compared with about one and a half points for naproxen. Among patients who started with normal blood pressure, roughly twenty-three percent of ibuprofen users developed hypertension over the study period, compared with nineteen percent of naproxen users.

A few points of blood pressure may not sound like much, but in someone who already runs high or takes blood pressure medication, it matters. Both drugs affect the kidneys by influencing how sodium and water are handled, which is the mechanism behind the blood pressure bump. If you have hypertension or kidney concerns, naproxen appears to be the slightly gentler option on blood pressure, though neither drug is harmless in this regard.

Stomach and Gut Risks

Gastrointestinal bleeding is the classic worry with any NSAID. A recent systematic review and meta-analysis that ranked individual NSAIDs by GI bleeding risk found that ibuprofen carried the lowest significant risk among non-selective NSAIDs, with an odds ratio of about two and a third compared with non-users. Naproxen’s GI risk is generally considered moderate within the NSAID class, higher than ibuprofen’s but lower than drugs like piroxicam or ketorolac.

Part of the explanation is dose exposure over time. Because naproxen lingers in the body longer, the stomach lining spends more hours exposed to the drug during each dosing cycle. If you have a history of ulcers, gastritis, or GI bleeding, ibuprofen’s shorter duration of gut contact could be an advantage, especially at low doses taken only when needed. Adding a proton pump inhibitor when using any NSAID regularly is a common strategy to reduce this risk.

The Aspirin Interaction

Millions of people take low-dose aspirin daily for heart protection. If you are one of them, which NSAID you add on top matters. Ibuprofen can compete with aspirin for the same binding site on platelets, potentially blocking aspirin’s ability to prevent blood clots. If you take ibuprofen before or at the same time as your aspirin, the aspirin may not do its job fully.

Naproxen behaves differently. In a controlled study, naproxen actually enhanced aspirin’s anti-clotting effect over twenty-four hours, an interaction not seen with the other NSAIDs tested. The interaction with ibuprofen can be worked around by timing, taking aspirin at least thirty minutes before ibuprofen, but many people do not manage that consistently. For regular aspirin users who also need an NSAID, naproxen is generally the safer pairing.

Why the Same Drug Works Differently for Different People

If you have ever wondered why ibuprofen seems to work great for your friend but does nothing for you, genetics may be part of the answer. Both ibuprofen and naproxen are broken down in the liver primarily by an enzyme called CYP2C9. Genetic variants of this enzyme are surprisingly common, and people who carry certain reduced-function versions clear ibuprofen more slowly, leading to higher drug levels in the blood for longer periods. That can mean better pain relief for some people but also a higher risk of side effects like stomach damage.

The frequency of these gene variants differs across populations. People of Central/South Asian, Near Eastern, and European descent are roughly six to eight times more likely to carry reduced-function CYP2C9 variants than people of Sub-Saharan African or East Asian descent. Clinical pharmacogenetics guidelines now recommend considering CYP2C9 status when prescribing NSAIDs, because it can influence both metabolism and safety. Most people will never get pharmacogenomic testing for an over-the-counter painkiller, but if you have noticed that a standard dose of ibuprofen hits you unusually hard or gives you stomach trouble, slow metabolism could be the reason.

NSAIDs and Bone Healing

A question that often comes up after fractures or orthopedic surgery is whether NSAIDs slow bone repair. The concern is biologically plausible: the inflammatory process that these drugs suppress is also part of the early stages of bone healing. A comprehensive review of the evidence found that animal and lab studies are deeply conflicting, with some showing impaired healing and others showing no effect. Even experiments using identical setups have produced opposing results. In the absence of strong clinical evidence either way, the review’s authors suggested treating NSAIDs as a potential risk factor for bone healing impairment and avoiding them in patients who are already at high risk for poor healing.

This concern applies equally to ibuprofen and naproxen. If you have a fresh fracture or have just come out of surgery, your doctor may steer you toward acetaminophen or other options until the early healing window passes. The worry is theoretical enough that plenty of orthopedic surgeons still allow short courses of NSAIDs, but it is worth asking about if you are healing bone.

Topical Alternatives

If the inflammation you are dealing with is in a joint close to the skin surface, like a knee or a hand, topical NSAID creams and gels are worth considering. A Cochrane review of topical NSAIDs for chronic musculoskeletal pain found that topical formulations significantly reduced pain over six to twelve weeks, with about sixty percent of participants experiencing substantial improvement. The main advantage is that very little of the drug reaches the bloodstream, which dramatically reduces the GI, cardiovascular, and kidney risks that come with swallowing pills.

Topical ibuprofen gels are available over the counter in many countries. Topical naproxen is less commonly found in consumer products, but topical diclofenac, a close pharmacological relative, is widely available by prescription and in some over-the-counter formulations. For localized inflammation that does not involve deep structures, going topical may sidestep the entire ibuprofen-versus-naproxen tradeoff.

NSAIDs in Waterways

One lesser-known angle to these drugs is what happens after they leave your body. Both ibuprofen and naproxen are among the most commonly detected pharmaceuticals in wastewater and river systems worldwide. In a study of water samples from a South African province, ibuprofen was the most frequently detected pharmaceutical, with peak river concentrations reaching roughly nineteen micrograms per liter, more than double the concentration of naproxen detected in the same samples. The ecological effects of chronic low-level NSAID exposure on aquatic organisms are still being studied, but ibuprofen’s dominance in environmental samples reflects its status as the world’s most widely used NSAID. Given that ibuprofen’s shorter half-life requires more frequent dosing, the total amount passing through sewage systems over a treatment course can be substantial. This is not a reason to choose one drug over the other for your own body, but it is a reminder that these are biologically active compounds that do not simply vanish after you flush.